Description
Texcell is a leading provider of biosafety services, specialising in therapeutic safety for medical devices, biologics, and advanced therapies, including cell and gene therapies.
With decades of expertise, Texcell supports its clients in bringing therapeutic products to market with the highest levels of safety and compliance. The company focuses on viral safety and clearance, offering comprehensive solutions across all stages of pharmaceutical development, from preclinical to clinical phases. Texcell works globally with clients to safeguard the health of patients worldwide.
Key Products and Services
- Cell Banking
- Viral Safety and Clearance
- BioAssays (In vitro and In vivo)
- BioManufacturing
Texcell’s commitment to biosafety ensures that the next generation of medicines is safe, effective, and ready for patient use.
Capabilities
- Analytical Services
- Biological Testing
- Biologics
- Bioprocess Validation
- Bioprocessing
- Cell and Gene Therapy
- Cell Culture Media Development
- Contract Development and Manufacturing (CDMO)
- Downstream Processing
- Laboratory and Analytical Services
- Mammalian Cell Culture
- Process Development
- Process Validation Studies
- Protein and Peptide
- Regulatory Services
- Validation
- Virology
Contact Information
Related Listings

CDMO Live Europe 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st May 2026

External Manufacturing Leaders Boston 2026
Exclusive event for senior external manufacturing leaders. Boston, January 2026











